Subscribe To
ALPMY / Astellas Pharma Inc. (ALPMF) Q3 2022 Earnings Call Transcript
ALPMY News
By Zacks Investment Research
October 2, 2023
New Strong Sell Stocks for October 2nd
ALPMY, BTDPY and ALRS have been added to the Zacks Rank #5 (Strong Sell) List on October 2, 2023. more_horizontal
By Zacks Investment Research
September 26, 2023
New Strong Sell Stocks for September 26th
ALPMY, ASH and DHC have been added to the Zacks Rank #5 (Strong Sell) List on September 26, 2023. more_horizontal
By Zacks Investment Research
September 18, 2023
New Strong Sell Stocks for September18th
ALPMY, CBRE and FMAO have been added to the Zacks Rank #5 (Strong Sell) List on September 18, 2023. more_horizontal
By Reuters
September 6, 2023
Astellas withdraws lawsuit challenging Medicare drug price negotiation plans
Japan-based Astellas Pharma on Wednesday withdrew a lawsuit filed against the U.S. government, days after its prostate cancer drug was spared from the more_horizontal
By MarketBeat
September 1, 2023
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Major pharmaceutical companies including Johnson & Johnson NYSE: JNJ, Novartis AG NYSE: NVS, Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. N more_horizontal
By Zacks Investment Research
August 21, 2023
New Strong Sell Stocks for August 21st
ALPMY, CYRX and DRCT have been added to the Zacks Rank #5 (Strong Sell) List on August 21, 2023. more_horizontal
By Seeking Alpha
April 29, 2023
Astellas Pharma Inc. (ALPMF) Q4 2022 Earnings Call Transcript
Astellas Pharma Inc. (OTCPK:ALPMF) Q4 2022 Results Conference Call April 27, 2023 3:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Ad more_horizontal
By Seeking Alpha
February 6, 2023
Astellas Pharma Inc. (ALPMF) Q3 2022 Earnings Call Transcript
Astellas Pharma Inc. (OTCPK:ALPMF) Q3 2022 Earnings Conference Call February 6, 2023 1:30 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, more_horizontal